Daniel J. Brennan sold $871k of BSX
EVP and CFO at BOSTON SCIENTIFIC CORP. 9,689 shares at an average of $89.86, traded Jan 3, 2025, filed Jan 3, 2025.
Score components
- +22RoleCFO
- +23Trade size$871k at market
- 0Share of holdings soldSold 4.1% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-000201, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 1, 2025 | MOption exercise Common Stock10b5-1 | +14,901 | $0.00 | $0 | 238,822 | Jan 3, 2025 |
| Jan 1, 2025 | FTax withholding Common Stock10b5-1 | -5,212 | $89.32 | $466k | 233,610 | Jan 3, 2025 |
| Jan 3, 2025 | SOpen-market sale Common Stock10b5-1 | -9,689 | $89.86 | $871k | 223,921 | Jan 3, 2025 |
| Jan 1, 2025 | MOption exercise Performance Share Unitsderivative10b5-1 | -14,901 | $0.00 | $0 | 0 | Jan 3, 2025 |
Related signals
Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $487k 4,826 shares | -11% | |
| 37Weak | BOSTON SCIENTIFIC CORP | Emily Woodworth SVP, Global Controller and CAO | $801k 7,631 shares | -95% | |
| 40Moderate | BOSTON SCIENTIFIC CORP | Emily Woodworth SVP, Global Controller and CAO | $1000k 9,887 shares | -86% | |
| 37Weak | BOSTON SCIENTIFIC CORP | Jeffrey B. Mirviss EVP&Pres, Periph Intervent | $767k 7,363 shares | -22% | |
| 45Moderate | BOSTON SCIENTIFIC CORP | Ellen M Zane director | $1.4M 13,586 shares | -28% | |
| 28Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $505k 4,826 shares | -10% | |
| 37Weak | BOSTON SCIENTIFIC CORP | Daniel J. Brennan EVP and CFO | $8.9M 84,863 shares | -34% | |
| 21Weak | BOSTON SCIENTIFIC CORP | Jeffrey B. Mirviss EVP&Pres, Periph Intervent | $159k 1,510 shares | -4% | |
| 35Weak | BOSTON SCIENTIFIC CORP | John Bradley Sorenson EVP, Global Operations | $625k 5,960 shares | -22% | |
| 6Weak | BOSTON SCIENTIFIC CORP | John Bradley Sorenson EVP, Global Operations | $128k 1,201 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.